Events

Nicola Richmond, VP Artificial Intelligence, will discuss AI in the drug discovery target identification process at the ELRIG Drug Discovery 2022 conference.

Ivan Griffin, BenevolentAI’s COO and Co-Founder, will join this webinar with Oliver Wyman to cover how AI and machine learning can transform drug discovery.

Join Dane Corneil, Lead AI Scientist, for Target Identification, for a keynote on “Large Language Models for Target Identification” at the AI-Driven Drug Discovery Summit

Join BenevolentAI's CEO, Joanna Shields, at the Morgan Stanley Putting the Tech in Biotech Conference